CA1316830C - Agent servant a traiter ou a prevenir la thrombocytopenie - Google Patents

Agent servant a traiter ou a prevenir la thrombocytopenie

Info

Publication number
CA1316830C
CA1316830C CA000579395A CA579395A CA1316830C CA 1316830 C CA1316830 C CA 1316830C CA 000579395 A CA000579395 A CA 000579395A CA 579395 A CA579395 A CA 579395A CA 1316830 C CA1316830 C CA 1316830C
Authority
CA
Canada
Prior art keywords
group
agent
treating
compound
thrombocytopenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000579395A
Other languages
English (en)
Inventor
Ken Masuo
Toshiro Nakayasu
Atsuo Inoue
Toru Masaoka
Teruo Takayanagi
Eiro Tsubura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to CA000579395A priority Critical patent/CA1316830C/fr
Application granted granted Critical
Publication of CA1316830C publication Critical patent/CA1316830C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000579395A 1988-10-05 1988-10-05 Agent servant a traiter ou a prevenir la thrombocytopenie Expired - Fee Related CA1316830C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000579395A CA1316830C (fr) 1988-10-05 1988-10-05 Agent servant a traiter ou a prevenir la thrombocytopenie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000579395A CA1316830C (fr) 1988-10-05 1988-10-05 Agent servant a traiter ou a prevenir la thrombocytopenie

Publications (1)

Publication Number Publication Date
CA1316830C true CA1316830C (fr) 1993-04-27

Family

ID=4138860

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000579395A Expired - Fee Related CA1316830C (fr) 1988-10-05 1988-10-05 Agent servant a traiter ou a prevenir la thrombocytopenie

Country Status (1)

Country Link
CA (1) CA1316830C (fr)

Similar Documents

Publication Publication Date Title
WO2001060381B1 (fr) Analogues de nucleoside a base bicyclique modifiee par carboxamidine
JP3192141B2 (ja) 抗うつ剤
JP4057648B2 (ja) 造血前駆細胞の増殖を促進するチオール類
KR100424503B1 (ko) 암전이억제제
EP0495116B1 (fr) Agent anti-vih
JP2526059B2 (ja) 抗潰瘍剤
EP0344880A2 (fr) Compositions pharmaceutiques à activité anticancéreuse
CA2057900A1 (fr) Methode de protection contre les effets secondaires et la toxicite de l'azt
EP0104826A2 (fr) Immunomodulateur et méthode d'utilisation pour immunomodulation
CA1316830C (fr) Agent servant a traiter ou a prevenir la thrombocytopenie
WO1989005637A1 (fr) Courbes de toxicite ameliorees en chimiotherapie
US5037804A (en) Agent for preventing and treating thrombocytopenia
US5424296A (en) 2-Halo-2'-deoxyadenosines as therapeutic agents against malignant astrocytoma
EP0500953A1 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
EP0290817B1 (fr) Utilisation d'oxétanocine pour inhiber HIV
US3988461A (en) Pharmaceutical composition for the treatment of Parkinson's disease
EP0350650A1 (fr) Composition thérapeutique pour l'encéphalopathie hépatique
US4298611A (en) Process for reducing blood pressure in animals
WO1983002893A1 (fr) Composition medicinale pour le traitement de certaines nevroviroses
EP0464206A1 (fr) Medicament ameliorant les fonctions cerebrales
JP2710638B2 (ja) 膵臓疾患治療剤
JPH05504130A (ja) 腫瘍壊死因子拮抗剤
WO1991004047A1 (fr) Effet synergique de l'interference beta de recombinaison humain sur des pyrimidines halogenees
JP2579486B2 (ja) 中枢神経抑制剤
EP0729950A1 (fr) Medicament anti-vih

Legal Events

Date Code Title Description
MKLA Lapsed